1. Home
  2. HAE vs ICHR Comparison

HAE vs ICHR Comparison

Compare HAE & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$105.01

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Logo Ichor Holdings

ICHR

Ichor Holdings

HOLD

Current Price

$65.35

Market Cap

3.0B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
HAE
ICHR
Founded
1971
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.0B
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
HAE
ICHR
Price
$105.01
$65.35
Analyst Decision
Buy
Strong Buy
Analyst Count
9
6
Target Price
$84.13
$49.50
AVG Volume (30 Days)
713.3K
915.0K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.72
N/A
Revenue
$910,373,000.00
$947,652,000.00
Revenue This Year
N/A
$20.51
Revenue Next Year
$5.23
$17.08
P/E Ratio
$125.38
N/A
Revenue Growth
N/A
11.61
52 Week Low
$47.32
$14.06
52 Week High
$92.25
$113.58

Technical Indicators

Market Signals
Indicator
HAE
ICHR
Relative Strength Index (RSI) 83.12 40.25
Support Level $79.52 $61.20
Resistance Level N/A $75.84
Average True Range (ATR) 3.10 5.33
MACD 1.15 0.08
Stochastic Oscillator 93.64 8.24

Price Performance

Historical Comparison
HAE
ICHR

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

About ICHR Ichor Holdings

Ichor Holdings Ltd designs, engineers, and manufactures critical fluid delivery subsystems and components mainly for semiconductor capital equipment, along with solutions for defense/aerospace and medical industries. Its product portfolio includes gas and chemical delivery subsystems that enable precise delivery, monitoring, and control of specialized gases and reactive liquid chemistries used in semiconductor manufacturing processes such as etch, electroplating, and cleaning. The company also provides precision-machined components, weldments, e-beam and laser-welded components, as well as precision vacuum and hydrogen brazing. Geographically, the company operates across the United States, Singapore, Europe, and other regions, with Singapore contributing the majority of revenue.

Share on Social Networks: